These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19928382)

  • 1. The roles of dopamine transport inhibition and dopamine release facilitation in wake enhancement and rebound hypersomnolence induced by dopaminergic agents.
    Gruner JA; Marcy VR; Lin YG; Bozyczko-Coyne D; Marino MJ; Gasior M
    Sleep; 2009 Nov; 32(11):1425-38. PubMed ID: 19928382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain.
    Karoum F; Chrapusta SJ; Brinjak R; Hitri A; Wyatt RJ
    Br J Pharmacol; 1994 Dec; 113(4):1391-9. PubMed ID: 7889297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cocaine self-administration produces pharmacodynamic tolerance: differential effects on the potency of dopamine transporter blockers, releasers, and methylphenidate.
    Ferris MJ; Calipari ES; Mateo Y; Melchior JR; Roberts DC; Jones SR
    Neuropsychopharmacology; 2012 Jun; 37(7):1708-16. PubMed ID: 22395730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of the biogenic amine transporters 15. Identification of novel allosteric dopamine transporter ligands with nanomolar potency.
    Rothman RB; Ananthan S; Partilla JS; Saini SK; Moukha-Chafiq O; Pathak V; Baumann MH
    J Pharmacol Exp Ther; 2015 Jun; 353(3):529-38. PubMed ID: 25788711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of pharmacological and wake-promoting properties of the dopaminergic stimulant sydnocarb in rats.
    Gruner JA; Mathiasen JR; Flood DG; Gasior M
    J Pharmacol Exp Ther; 2011 May; 337(2):380-90. PubMed ID: 21300706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function of dopamine transporter is compromised in DYT1 transgenic animal model in vivo.
    Hewett J; Johanson P; Sharma N; Standaert D; Balcioglu A
    J Neurochem; 2010 Apr; 113(1):228-35. PubMed ID: 20132487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants.
    Nishino S; Mao J; Sampathkumaran R; Shelton J
    Sleep Res Online; 1998; 1(1):49-61. PubMed ID: 11382857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action of methylmercury on in vivo striatal dopamine release. Possible involvement of dopamine transporter.
    Faro LR; do Nascimento JL; Alfonso M; Durán R
    Neurochem Int; 2002 Apr; 40(5):455-65. PubMed ID: 11821154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cocaine-insensitive dopamine transporters with intact substrate transport produced by self-administration.
    Ferris MJ; Mateo Y; Roberts DC; Jones SR
    Biol Psychiatry; 2011 Feb; 69(3):201-7. PubMed ID: 20801429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Dopamine Release by Dopamine Transport Inhibitors Described by a Restricted Diffusion Model and Fast-Scan Cyclic Voltammetry.
    Hoffman AF; Spivak CE; Lupica CR
    ACS Chem Neurosci; 2016 Jun; 7(6):700-9. PubMed ID: 27018734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluctuation of the dopamine uptake inhibition potency of cocaine, but not amphetamine, at mammalian cells expressing the dopamine transporter.
    Ukairo OT; Ramanujapuram S; Surratt CK
    Brain Res; 2007 Feb; 1131(1):68-76. PubMed ID: 17169338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine transporter mediated release of dopamine: role of chloride.
    Sitges M; Reyes A; Chiu LM
    J Neurosci Res; 1994 Sep; 39(1):11-22. PubMed ID: 7807588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine transporter function fluctuates across sleep/wake state: potential impact for addiction.
    Alonso IP; Pino JA; Kortagere S; Torres GE; España RA
    Neuropsychopharmacology; 2021 Mar; 46(4):699-708. PubMed ID: 33032296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes.
    Zhu J; Mactutus CF; Wallace DR; Booze RM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1071-83. PubMed ID: 19325033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine uptake inhibitors but not dopamine releasers induce greater increases in motor behavior and extracellular dopamine in adolescent rats than in adult male rats.
    Walker QD; Morris SE; Arrant AE; Nagel JM; Parylak S; Zhou G; Caster JM; Kuhn CM
    J Pharmacol Exp Ther; 2010 Oct; 335(1):124-32. PubMed ID: 20605908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for presynaptic mechanisms in the actions of nomifensine and haloperidol.
    Garris PA; Budygin EA; Phillips PE; Venton BJ; Robinson DL; Bergstrom BP; Rebec GV; Wightman RM
    Neuroscience; 2003; 118(3):819-29. PubMed ID: 12710989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.
    Scarponi M; Bernardi G; Mercuri NB
    Eur J Neurosci; 1999 Feb; 11(2):593-8. PubMed ID: 10051759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SKF-83566, a D1-dopamine receptor antagonist, inhibits the dopamine transporter.
    Stouffer MA; Ali S; Reith ME; Patel JC; Sarti F; Carr KD; Rice ME
    J Neurochem; 2011 Sep; 118(5):714-20. PubMed ID: 21689106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of dopamine transporter after chronic self-administration of bupropion and nomifensine.
    Tella SR; Ladenheim B; Cadet JL
    J Pharmacol Exp Ther; 1997 Apr; 281(1):508-13. PubMed ID: 9103538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo dopamine clearance rate in rat striatum: regulation by extracellular dopamine concentration and dopamine transporter inhibitors.
    Zahniser NR; Larson GA; Gerhardt GA
    J Pharmacol Exp Ther; 1999 Apr; 289(1):266-77. PubMed ID: 10087014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.